Developing a new implant to heal joint cartilage damage
Synthetic Cartilage-Capped, Regenerative Osteochondral Plugs to Heal Osteochondral Defects
This study is testing a new type of implant that helps heal joint damage in knees by combining a special cartilage cap with a base that encourages bone growth, making it a friendly option for people with osteochondral defects looking to relieve pain and improve joint function.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas Engineering Experiment Station NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-11247210 on NIH RePORTER |
What this research studies
This research focuses on creating a bioprosthetic implant called a cartilage-capped, regenerative osteochondral plug (CC-ROP) to treat osteochondral defects (OCDs) in joints like the knees. The CC-ROP combines a synthetic cartilage cap with a biodegradable base that encourages new bone growth, aiming to restore joint function and reduce pain. The implant is designed to integrate with surrounding tissues and can be inserted using existing surgical techniques, making it a practical option for patients. The study will evaluate the effectiveness of this innovative approach compared to traditional treatments such as autografting and allografting.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with osteochondral defects in their knees or other joints who are seeking treatment options.
Not a fit: Patients with advanced osteoarthritis or those who have already undergone multiple joint surgeries may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a more effective treatment option for patients suffering from osteochondral defects, potentially reducing pain and improving joint function.
How similar studies have performed: Other research has shown promise in using bioprosthetic implants for joint repair, indicating that this approach may lead to successful outcomes.
Where this research is happening
College Station, United States
- Texas Engineering Experiment Station — College Station, United States (Active)
Researchers
- Principal investigator: Grunlan, Melissa — Texas Engineering Experiment Station
- Study coordinator: Grunlan, Melissa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.